posted by:
Wendy W. Blackburn
at 2:03 PM
October 7, 2010
The industry is waiting with bated breath for guidance from FDA on the use of the Internet and social media for promotion of pharmaceutical products. When can we expect it and what will it mean? When Can We Expect It?
As recently as June, FDA was quoted in print as saying they ...
posted by:
Wendy W. Blackburn
at 6:17 PM
September 29, 2010
I enjoyed hearing many new ideas and seeing friends old and new at the ePatient Connections Conference this week. Kudos to @KevinKruse for another great event! Unfortunately I came down with a nasty cold the second day and missed many of the presentations. Overall I understand it was a successful ...
posted by:
Wendy W. Blackburn
at 11:55 AM
September 21, 2010
I'm excited to announce a new initiative from my agency that I hope will help pharmaceutical companies take a new look at social sharing. It's called share»send»save, and its the industry's first "pharma-friendly" social sharing widget. The share»send»save widget enables ...
posted by:
Wendy W. Blackburn
at 10:43 AM
September 15, 2010
Time and again over the past few weeks, I've seen something that is so very true, and I am sure something that all marketers and agencies struggle with when developing digital assets. For this exercise, let’s pretend we’re building a Web site. If any one department or practice had complete ...
posted by:
Wendy W. Blackburn
at 11:32 AM
September 7, 2010
On Friday, Reuters published a "Special Report" on FDA's increased enfocement on drug advertising.
I tweeted about this a few times over the past few days, but if you don't follow Twitter you may not have seen it. And since I've highlighted a lot of FDA social media and ...